Emcure Pharmaceuticals Approves Board Changes and Leadership Re-Appointments at AGM
Emcure Pharmaceuticals Ltd 路 Others (Uncategorized) 路 23 Sept 2026, 11:58 pm
Emcure Pharmaceuticals Approves Board Changes and Leadership Re-Appointments at AGM At its 45th AGM on 21st Sep'26, Emcure Pharmaceuticals' shareholders approved key board leadership changes. Chairman and Non-Executive Non-Independent Director Berjis Desai retired effective 21st Sep'26. MD & CEO Satish Mehta secured a five-year re-appointment commencing 1st Apr'27, while Whole-time Director Dr. Mukund Gurjar was re-appointed for one year effective 28th Aug'26. Additionally, Raghu Kumar was appointed as an Independent Director for a three-year term effective 6th Aug'26.
Original exchange filing (PDF)
More announcements from Emcure Pharmaceuticals Ltd
- Intimation of Cancellation of schedule of Analyst / Investor Meeting(s) scheduled on November 16, 2026 路 15 Nov 2026
- Transcript of Earnings Call - Q2 FY27 held on Tuesday, November 03, 2026 at 4:00 p.m. (IST) 路 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting dated Monday, November 16, 2026 路 06 Nov 2026
- Intimation of schedule of Analyst/Investor Meeting on Monday, November 16, 2026 路 06 Nov 2026
- Audio recording of Earnings Call - Q2 FY27 路 04 Nov 2026
- Presentation on Unaudited Financial Results for the quarter ended September 30, 2026 路 03 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026 路 03 Nov 2026
- Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
